March 15, 2018 / 11:38 AM / 2 years ago

BRIEF-Albireo Reports Fourth Quarter And Year-End 2017 Financial Results

March 15 (Reuters) - Albireo Pharma Inc:

* ALBIREO REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

* ALBIREO PHARMA INC - ABOUT $200 MILLION CURRENT CASH BALANCE EXPECTED TO BE SUFFICIENT TO FUND OPERATIONS INTO 2021

* ALBIREO PHARMA INC - PHASE 3 PFIC TRIAL OF IBAT INHIBITOR A4250 PLANNED TO INITIATE IN SPRING 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below